Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard E. Clark

Showing results (21-30 of 115) with videos related to

Pageof 12
Sort By:
Haematologica|February 10, 2015
c-Myc inhibition decreases CIP2A and reduces BCR-ABL1 tyrosine kinase activity in chronic myeloid leukemiaClaire M Lucas, Robert J Harris, Athina Giannoudis, et al.
Journal of Biomedical Informatics|January 26, 2010
Intra-operative decision making: more than meets the eyeCarla M Pugh, Susan Santacaterina, Debra A DaRosa, et al.
British Journal of Haematology|August 16, 2002
Serial monitoring of BCR-ABL by peripheral blood real-time polymerase chain reaction predicts the marrow cytogenetic response to imatinib mesylate in chronic myeloid leukaemiaLihui Wang, Kevin Pearson, Lynne Pillitteri, et al.
The Annals of Thoracic Surgery|January 4, 2014
The STS National DatabaseFrederick L Grover, David M Shahian, Richard E Clark, et al.
Haematologica|September 7, 2014
Low leukotriene B4 receptor 1 leads to ALOX5 downregulation at diagnosis of chronic myeloid leukemiaClaire M Lucas, Robert J Harris, Athina Giannoudis, et al.
Leukemia Research|February 28, 2007
Evidence that a BCR-ABL fusion peptide does not induce lymphocyte proliferation or cytokine production in vitroHazem M Abu-Eisha, Nauman M Butt, Richard E Clark, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|March 27, 2014
The use of cognitive task analysis to reveal the instructional limitations of experts in the teaching of procedural skillsMaura E Sullivan, Kenneth A Yates, Kenji Inaba, et al.
NPJ Systems Biology and Applications|October 16, 2025
Predicting treatment-free remission in chronic myeloid leukemia patients using an integrated model of tumor-immune dynamicsArtur C Fassoni, Agnes S M Yong, Richard E Clark, et al.
Blood|April 9, 2004
BCR-ABL-specific T cells can be detected in healthy donors and in chronic myeloid leukemia patients following allogeneic stem cell transplantationNauman M Butt, Lihui Wang, Hazem M Abu-Eisha, et al.
Blood|August 2, 2008
Effective dasatinib uptake may occur without human organic cation transporter 1 (hOCT1): implications for the treatment of imatinib-resistant chronic myeloid leukemiaAthina Giannoudis, Andrea Davies, Claire M Lucas, et al.
Pageof 12

Showing results (21-30 of 115) with videos related to

Sort By:
Pageof 12
Haematologica|February 10, 2015
c-Myc inhibition decreases CIP2A and reduces BCR-ABL1 tyrosine kinase activity in chronic myeloid leukemiaClaire M Lucas, Robert J Harris, Athina Giannoudis, et al.
Journal of Biomedical Informatics|January 26, 2010
Intra-operative decision making: more than meets the eyeCarla M Pugh, Susan Santacaterina, Debra A DaRosa, et al.
British Journal of Haematology|August 16, 2002
Serial monitoring of BCR-ABL by peripheral blood real-time polymerase chain reaction predicts the marrow cytogenetic response to imatinib mesylate in chronic myeloid leukaemiaLihui Wang, Kevin Pearson, Lynne Pillitteri, et al.
The Annals of Thoracic Surgery|January 4, 2014
The STS National DatabaseFrederick L Grover, David M Shahian, Richard E Clark, et al.
Haematologica|September 7, 2014
Low leukotriene B4 receptor 1 leads to ALOX5 downregulation at diagnosis of chronic myeloid leukemiaClaire M Lucas, Robert J Harris, Athina Giannoudis, et al.
Leukemia Research|February 28, 2007
Evidence that a BCR-ABL fusion peptide does not induce lymphocyte proliferation or cytokine production in vitroHazem M Abu-Eisha, Nauman M Butt, Richard E Clark, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|March 27, 2014
The use of cognitive task analysis to reveal the instructional limitations of experts in the teaching of procedural skillsMaura E Sullivan, Kenneth A Yates, Kenji Inaba, et al.
NPJ Systems Biology and Applications|October 16, 2025
Predicting treatment-free remission in chronic myeloid leukemia patients using an integrated model of tumor-immune dynamicsArtur C Fassoni, Agnes S M Yong, Richard E Clark, et al.
Blood|April 9, 2004
BCR-ABL-specific T cells can be detected in healthy donors and in chronic myeloid leukemia patients following allogeneic stem cell transplantationNauman M Butt, Lihui Wang, Hazem M Abu-Eisha, et al.
Blood|August 2, 2008
Effective dasatinib uptake may occur without human organic cation transporter 1 (hOCT1): implications for the treatment of imatinib-resistant chronic myeloid leukemiaAthina Giannoudis, Andrea Davies, Claire M Lucas, et al.
Pageof 12